Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025
Venus Concept (NASDAQ: VERO), a global medical aesthetic technology leader, has scheduled its second quarter fiscal year 2025 financial results release for August 14, 2025 after market close.
The company will host a conference call at 5:00 p.m. Eastern Time on the same day, featuring a management discussion and Q&A session. Participants can join via phone using access code 13754867 or watch the live webcast on the company's investor relations website. A two-week replay will be available for those unable to attend.
Venus Concept (NASDAQ: VERO), leader globale nella tecnologia medica estetica, ha programmato la pubblicazione dei risultati finanziari del secondo trimestre dell'anno fiscale 2025 per il 14 agosto 2025 dopo la chiusura del mercato.
La società terrà una conference call alle 17:00 ora della costa orientale lo stesso giorno, con una presentazione del management seguita da una sessione di domande e risposte. I partecipanti potranno collegarsi telefonicamente utilizzando il codice di accesso 13754867 o seguire la diretta streaming sul sito web delle relazioni con gli investitori dell'azienda. Sarà disponibile una registrazione per due settimane per chi non potrà partecipare.
Venus Concept (NASDAQ: VERO), líder global en tecnología médica estética, ha programado la publicación de sus resultados financieros del segundo trimestre del año fiscal 2025 para el 14 de agosto de 2025 después del cierre del mercado.
La compañía realizará una llamada conferencia a las 5:00 p.m., hora del Este ese mismo día, que incluirá una presentación de la dirección y una sesión de preguntas y respuestas. Los participantes podrán unirse por teléfono usando el código de acceso 13754867 o ver la transmisión en vivo en el sitio web de relaciones con inversores de la empresa. Habrá una repetición disponible durante dos semanas para quienes no puedan asistir.
Venus Concept (NASDAQ: VERO)는 글로벌 의료 미용 기술 선도 기업으로, 2025 회계연도 2분기 재무 실적 발표를 2025년 8월 14일 장 마감 후에 진행할 예정입니다.
회사는 같은 날 동부 표준시 오후 5시에 경영진 발표 및 질의응답 세션이 포함된 컨퍼런스 콜을 개최합니다. 참가자는 전화로 접속 코드 13754867을 사용해 참여하거나 회사 투자자 관계 웹사이트에서 라이브 웹캐스트를 시청할 수 있습니다. 참석하지 못하는 분들을 위해 2주간 재방송도 제공됩니다.
Venus Concept (NASDAQ : VERO), leader mondial des technologies esthétiques médicales, a programmé la publication de ses résultats financiers du deuxième trimestre de l'exercice 2025 pour le 14 août 2025 après la clôture des marchés.
La société tiendra une conférence téléphonique à 17h00, heure de l'Est le même jour, comprenant une présentation de la direction suivie d'une session de questions-réponses. Les participants pourront se joindre par téléphone en utilisant le code d'accès 13754867 ou regarder la diffusion en direct sur le site des relations investisseurs de l'entreprise. Une rediffusion sera disponible pendant deux semaines pour ceux qui ne pourront pas assister.
Venus Concept (NASDAQ: VERO), ein weltweit führendes Unternehmen im Bereich medizinischer ästhetischer Technologien, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal des Geschäftsjahres 2025 für den 14. August 2025 nach Börsenschluss geplant.
Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz abhalten, die eine Managementpräsentation und eine Frage-Antwort-Runde umfasst. Teilnehmer können per Telefon mit dem Zugangscode 13754867 teilnehmen oder die Live-Webcast auf der Investor-Relations-Website des Unternehmens verfolgen. Eine zweiwöchige Wiederholung wird für diejenigen verfügbar sein, die nicht teilnehmen können.
- None.
- None.
TORONTO, July 16, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2025 financial results will be released after the market closes on Thursday, August 14, 2025.
Management will host a conference call at 5:00 p.m. Eastern Time on August 14, 2025 to discuss the results of the quarter and host a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13754867. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.
For those unable to participate, a replay of the call will be available for two weeks at: 877-660-6853 (201-612-7415 for international callers); access code 13754867. The webcast will be archived at ir.venusconcept.com.
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa PRO, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, Masters Special Situations, and Madryn Asset Management, L.P.
Investor Relations Contact: ICR Healthcare on behalf of Venus Concept Mike Piccinino, CFA VenusConceptIR@ICRHealthcare.com
FAQ
When will Venus Concept (VERO) release Q2 2025 earnings?
How can I listen to Venus Concept's Q2 2025 earnings call?
What time is Venus Concept's Q2 2025 earnings call?
How can I access the replay of Venus Concept's Q2 2025 earnings call?
